Cardio Diagnostics Holdings Launches PrecisionCHD™ for Nationwide Detection of Coronary Heart Disease

Cardio Diagnostics Holdings, Inc has launched PrecisionCHD™, a blood-based detection test for coronary heart disease (CHD) that integrates epigenetic and genetic biomarkers with artificial intelligence. The test is the only detection technology that combines these elements and offers remote and scalable deployment capabilities across the US. It requires only a simple blood sample, making it far ..